Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1. Data from Large Observational Studies on Independent Risk Factors for Positive Status on Tests for Anti-Hepatitis C Virus Antibody *

Study (Reference) Setting Sample Size
(Prevalence of Anti-HCV Antibodies)
Risk Factors Evaluated Adjusted Odds Ratio for Independent Risk Factors for Positive HCV-Antibody Status (95% CI)

Alter et al. National Health and Nutrition Examination Survey III3

Population-based household sample in the United States

21, 241
(1.80% overall and 2.3% in adults ≥20 years)

  • Race or ethnicity.
  • Sex.
  • Marital status.
  • Poverty index.
  • Education.
  • Urban residence.
  • Region of residence.
  • Military service status.
  • Country of birth.
  • Healthcare worker.
  • Cocaine use.
  • Marijuana use.
  • Age at first sexual intercourse.
  • Number of lifetime sexual partners.
  • Herpes simplex 2 virus infection.

Marital status:
Divorced or separated: 1.70 (1.08-2.66)
Never married, married or widowed: 1.00

Education:
≤12 years: 1.92 (1.01-3.67)
<12 years: 1.00

Poverty index:
Below poverty level: 2.99 (1.69-5.27)
At or above poverty level: 1.00

Marijuana use:
≤100 times: 2.99 (1.69-5.27)
1-99 times: 1.15 (0.61-2.16)
Never: 1.00

Cocaine use:
Ever: 4.70 (2.49-8.87)
Never: 1.00

Number of sexual partners:
<50: 5.16 (1.80-14.73)
2-49: 2.54 (1.14-5.66)
0-1: 1.00

Age at first sexual intercourse:
<18 y: 2.94 (1.50-5.78)
≤18 y: 1.00

Kaur et al. National Hepatitis Screening Survey38

Screening program at 40 mostly urban centers in the United States

13, 997

(7.00%)

  • Age.
  • Sex.
  • Ethnicity.
  • Occupation.
  • Blood transfusion.
  • Hemodialysis.
  • Surgery.
  • Intravenous drug use.
  • Sex with intravenous drug user.
  • Sex with multiple partners.
  • Needle-stick injury.
  • Born in Southeast Asia or Africa.
  • Vaccinated for hepatitis B virus infection.

Sex:
Male: 3.60 (2.66-4.87)
Female: 1.00

Ethnicity:
White or Hispanic: 0.57 (0.39-0.83)
Other: 1.00

Blood transfusion:
Yes: 4.09 (2.97-5.62)
No: 1.00

Hemodialysis:
Yes: 10.95 (3.85-31.13)
No: 1.00

Intravenous drug use:
Yes: 23.34 (15.21-35.81)
No: 1.00

Sex with intravenous drug user:
Yes: 7.29 (4.74-11.21)
No: 1.00

Vaccinated for hepatitis B virus infection:
Yes: 0.37 (0.22-0.62)
No: 1.00

Bellentani et al. Dionysos Study37

Population-based study in Northern Italy

6 917

(3.2%)

  • Male sex.
  • Alcohol intake <30 g/day.
  • Hepatitis among the cohabiting.
  • Surgical procedure.
  • Dental procedures.
  • Intravenous drug use.
  • Acupuncture.
  • Blood transfusion.
  • Animal bites.
  • Homosexuality.

Hepatitis among cohabiting persons:
Yes: 2.0 (1.4-2.8)
No: 1.00

Intravenous drug use:
Yes: 18.4 (5.3-64.0)
No: 1.00

Animal bites:
Yes: 1.6 (1.0-2.5)
No: 1.00

Blood transfusion
Yes: 2.2 (1.4-3.4)
No: 1.00

Dubois et al2

Population-based study throughout France

6 283

(1.2%)

  • Past or present intravenous drug abuse.
  • Unemployment.
  • Tattoos.
  • History of transfusions.
  • Travel in developing countries.
  • Voluntary abortion.
  • Sexually transmitted disease.
  • Casual sex partners.
  • Sexual contact with intravenous drug users.
  • Surgery with major blood loss.
  • Acupuncture.
  • Injection with reusable glass syringe.
  • Dental surgery.
  • Sexual contact with HCV-positive partner.
  • Homosexual practices.
  • Education level.

Intravenous drug use:
Yes: 29.2 (3.8-225.7)
No: 1.00

History of transfusion:
Yes: 7.0 (1.7-15.1)
No: 1.00

Unemployment:
Yes: 3.1 (1.2-8.1)
No: 1.00

* HCV = hepatitis C virus

Return to Document

 

AHRQ Advancing Excellence in Health Care